Our experience in clinical use of new antifibrinolytic substance, AMCHA,** on several skin diseases has been reported already (1) .
We tried to prove the effectiveness of AMCHA again and intended to show the relation between plasmin activity in the blood and the effect of administration of AMCHA.
GENERAL METHOD OF CLINICAL EXAMINATION
1) The clinical status of patients was carefully observed and recorded ac cording to clinical routine in every consultation.
2) Aqueous solution of AMCHA was injected to patients every day as a rule. To infant patients 2 to 5 ml of 5% AMCHA solution was injected sub cutaneously or intravenously, and to the other patients 5 ml of the solution intravenously.
3)
Relating to the clinical examination, plasmin activity in the blood was also examined by routine methods. 5) Course and effect of treatment with AMCHA: Since May 22, 5 ml of 5% AMCHA solution was injected intravenously for seven days. After the second injection, itching and exudation began to decrease; after the seventh injection the lesion almost healed up, and scaling was observed. Blood examination was carried out at this time, and slightly accelerated euglobulin lysis was noticed.
AMCHA administration was interrupted for five days, and the recurrence of exudative lesion was seen on legs.
6) Side effect: None, and no remarkable change of laboratory ,data was also seen after AMCHA administration.
7) External application:
Boric acid and zinc ointment.
8) Result:
It is recognized that the administration of AMCHA was effec tive in treating autosensitization dermatitis, and plasmin activity became lower than before AMCHA treatment.
Others: Three cases of acute dermatitis with high plasmin activity and one case of autosensitization dermatitis, showed also high plasmin activity, have been treated with same method. In these cases the administration of AMCHA was conspicuously effective, and the plasmin activity showed normal after treatment (Table 1) . The results of our investigation showed that the administration of 5%
AMCHA solution was effective for treating all these cases, and that plasmin activity in blood became lower than before the administration.
No unfavorable side effect was observed.
